Dumalagan, Mary Joy .
HRN: 26-71-53 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/11/2025
CEFUROXIME 1.5GM (VIAL)
04/11/2025
04/17/2025
IV
1.5g
Q8
Cap LR
Waiting Final Action